Can you explain CIRM’s role in furthering stem cell therapies?


About CIRM:
CIRM was established in November 2004 with the passage of Proposition 71, the California Stem Cell Research and Cures Act. The statewide ballot measure, which provided $3 billion in funding for stem cell research at California universities and research institutions, was overwhelmingly approved by voters, and called for the establishment of an entity to make grants and provide loans for stem cell research, research facilities, and other vital research.

CIRM’s Mission:
“To support and advance stem cell research and regenerative medicine under the highest ethical and medical standards for the discovery and development of cures, therapies, diagnostics and research technologies to relieve human suffering from chronic disease and injury.”

Progress to Date:
To date, CIRM has provided over $1.8 billion in awards to 69 different California institutions, resulting in the publication of more than 1,200 journal articles and has provided funding for 77 translational projects in 38 therapeutic areas. CIRM has also provided funding for 43 translational projects in 26 therapeutic areas. In addition, CIRM funded the construction of 12 dedicated stem cell facilities ($271 million commitment of state funds resulted in more than $800 million in private donor and institutional funds for construction), and supported the relocation of more than 130 faculty level stem cell researchers into the state.

Additional information can be found at the following links:
About CIRM:
Progress toward therapies:
CIRM’s blog:

Pin It on Pinterest